EG 427 announces issuance of the first 2 patents for its HSV-based gene therapy treatment
· Issued European and Japanese patents cover herpes simplex virus (HSV) vectors selectively inhibiting subtype of sensory..
GlobeNewswire
Global Edition
Wednesday, April 24, 2024